ENLV icon

Enlivex Therapeutics

16 hedge funds and large institutions have $409K invested in Enlivex Therapeutics in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.

Holders
16
Holders Change
-3
Holders Change %
-15.79%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
4
Closed
4
Calls
$48K
Puts
$8K
Net Calls
+$40K
Net Calls Change
-$105K
Name Market Value Shares Shares
Change
Shares
Change %
CLOS
1
Compagnie Lombard Odier SCmA
Switzerland
$104K 65,000
Renaissance Technologies
2
Renaissance Technologies
New York
$93K 58,889 +2,200 +4%
Morgan Stanley
3
Morgan Stanley
New York
$69.8K 44,156 +305 +0.7%
Citadel Advisors
4
Citadel Advisors
Florida
$59.5K 37,683 -932 -2%
EDRH
5
Edmond de Rothschild Holding
Switzerland
$20.5K 13,000
SIGI
6
Susquehanna International Group (Ireland)
Ireland
$19.5K 12,326 -2,765 -18%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$16.5K 10,420
Wells Fargo
8
Wells Fargo
California
$14K 8,882
SPIA
9
Steward Partners Investment Advisory
New York
$4.74K 3,000
Barclays
10
Barclays
United Kingdom
$2K 1,000
JPMorgan Chase & Co
11
JPMorgan Chase & Co
New York
$1.9K 1,200 -1,179 -50%
Bank of America
12
Bank of America
North Carolina
$1.32K 838
UBS Group
13
UBS Group
Switzerland
$1.09K 690 -17,120 -96%
Osaic Holdings
14
Osaic Holdings
Arizona
$632 400
RTL
15
Red Tortoise LLC
Georgia
$237 150
Qube Research & Technologies (QRT)
16
Qube Research & Technologies (QRT)
United Kingdom
$2 1 +1 New
Simplex Trading
17
Simplex Trading
Illinois
-12,675 Closed
Goldman Sachs
18
Goldman Sachs
New York
-11,297 Closed
Group One Trading
19
Group One Trading
Illinois
-1,100 Closed
AAP
20
Arax Advisory Partners
Colorado
-290 Closed
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
CFGS
22
Concourse Financial Group Securities
Alabama